Metabolic Reprogramming Driven by Trophoblasts and Decidual XCR1 + PMN‐MDSC Crosstalk Controls Adverse Outcomes Associated With Advanced Maternal Age
Advanced Science · 2026
DOI: 10.1002/advs.202513370 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Meiqi Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Intensive Care Unit, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Department of Immunology, School of Ba…. Hauptthemen laut MEDLINE: Trophoblasts, Decidua, Myeloid-Derived Suppressor Cells. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation, Open Fund Project of Guangdong Academy of Medical Sciences.
Abstract (Originalsprache)
Trophoblast–immune cell communication is crucial during pregnancy, with impairments linked to adverse outcomes. The accumulation of decidual polymorphonuclear myeloid‐derived suppressor cells (dPMN‐MDSCs) in the third trimester is vital for fetal development. This study presents a novel crosstalk mechanism between trophoblasts and dPMN‐MDSCs that improves adverse outcomes associated with advanced maternal age (AMA). A specific dPMN‐MDSC population with high X‐C motif chemokine receptor 1 (XCR1) expression is identified, which interacts with trophoblasts through X‐C motif chemokine ligand 1 (XCL1) during the third trimester. Spontaneous fetal growth restriction observed in AMA and pregnant Xcr1 −/− mice is correlated with the disruption of this interaction. Mechanistically, the deficiency in XCL1–XCR1 expression reduces nuclear FOXO1 levels, thereby impairing the transcription of FOXO1‐driven oxidative phosphorylation genes in decidual XCR1 + PMN‐MDSCs. Restoring the expression of XCL1–XCR1 or FOXO1 in dPMN‐MDSCs mitigates this effect. Crucially, their adoptive transfer or treatment with XCL1/Oltipraz rescues the delayed fetal growth linked to impaired decidual XCR1 + PMN‐MDSCs and metabolic imbalance. Our findings highlight the importance of trophoblast–dPMN‐MDSC communication via the XCL1–XCR1 axis, proposing metabolic reprogramming of dPMN‐MDSCs as a potential immunotherapeutic strategy for AMA‐related adverse outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pediatric Intensive Care Unit, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Department of Immunology, School of Basic Medical Sciences, Department of Clinical Laboratory, The Third Aff…
- Department of Immunology School of Basic Medical Sciences, Guangdong Provincial Key Laboratory of Single-cell and Extracellular Vesicles, Southern Medical University, Guangzhou, China.
- Pediatric Intensive Care Unit, Guangdong Provincial Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University;Guangdong Provincial People's Hos…
- Department of Clinical Laboratory, The Third Affiliated Hospital of Southern Medical University, Southern Medical University, Guangzhou, China.
- Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- Department of Pediatric Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
ORCID-Profile: Yumei He
Förderung
- National Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research Foundation
- Open Fund Project of Guangdong Academy of Medical Sciences
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Chen, M., Guo, Y., Zhao, Q., Liu, J., Kuang, S., Huang, Z., Lv, C., Xu, S., Zhuang, Z., Yang, A., Li, J., Wu, K., & He, Y. (2026). Metabolic Reprogramming Driven by Trophoblasts and Decidual XCR1 + PMN‐MDSC Crosstalk Controls Adverse Outcomes Associated With Advanced Maternal Age. Advanced Science. https://doi.org/10.1002/advs.202513370
Vancouver
Chen M, Guo Y, Zhao Q, Liu J, Kuang S, Huang Z, et al. Metabolic Reprogramming Driven by Trophoblasts and Decidual XCR1 + PMN‐MDSC Crosstalk Controls Adverse Outcomes Associated With Advanced Maternal Age. Advanced Science. 2026. doi:10.1002/advs.202513370
BibTeX
@article{Chen2026,
author = {Chen, Meiqi and Guo, Yuxiong and Zhao, Qing and Liu, Jingping and Kuang, Shuyi and Huang, Zhengcong and Lv, Chenlin and Xu, Shuxiu and Zhuang, Zekai and Yang, Anyan and Li, Jing and Wu, Kai and He, Yumei},
title = {Metabolic Reprogramming Driven by Trophoblasts and Decidual XCR1 + PMN‐MDSC Crosstalk Controls Adverse Outcomes Associated With Advanced Maternal Age},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202513370}
}
EUVIMED